Register
Login:
Share:
Email Facebook Twitter

VIDEO EXCLUSIVE: TSX-listed Transglobe Energy Corporation considers London listing Watch here

VIDEO EXCLUSIVE: TSX-listed Transglobe Energy Corporation considers London listing


Sareum Share Chat (SAR)



Share Price: 0.85Bid: 0.80Ask: 0.90Change: -0.025 (-2.86%)Faller - Sareum
Spread: 0.10Spread as %: 12.50%Open: 0.875High: 0.875Low: 0.85Yesterday’s Close: 0.875


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Dr.Zed
Posts: 592
Off Topic
Opinion:No Opinion
Price:0.85
RE: Atr with Chk1
Today 16:38
Given that Sierra's share price has only ticked up 2% I don't see 1p tomorrow.

I'd love to be proven wrong. We've October's update to look forward to so here's hoping.

KR

ZA
 
Atomicrain
Posts: 5,999
Off Topic
Opinion:No Opinion
Price:0.85
RE: Atr with Chk1
Today 16:31
RNS tomorrow morning all is good lets see 1p.
JonBell
Posts: 646
Off Topic
Opinion:No Opinion
Price:0.85
Atr with Chk1
Today 16:26
Is an outstanding combo, according to the speaker. Wee1 inhibitors show more toxicity. Chk1 proving not to harm normal cells which has less stress replication than the cancer itself. Chk1 showing to be useful in multiple cancers.
An excellent question fired by a guy called rob from old Blighty pertaining to the above.

Lots of stuff above my head.

Lots of enthusiasm for Chk1 with parp atr

Looking good, looking great.

Love peace and harmony.
Thoth2
Posts: 1,598
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.85
so far
Today 16:11
hes talked about 2 potential strategies would be combos with Olaparib or a wee1 inhibitor (from my own research that would be astra then for both....). only potential strategies mind...
rata
Posts: 267
Off Topic
Opinion:No Opinion
Price:0.85
Any news...
Today 16:06
Update?
Thoth2
Posts: 1,598
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.85
RE: Presentation
Today 14:56
unfortunately at work. Ill listen later. Nothing earth shattering I expect. more the rationale for trial expansion as I suspect Sierra will spend quite a lot on them (new combo trials).
DonaldStump
Posts: 91
Off Topic
Opinion:No Opinion
Price:0.85
Presentation
Today 14:53
Anybody else signed up for the webcast?
JonBell
Posts: 646
Off Topic
Opinion:No Opinion
Price:0.85
View Thread (2)
Aim
Today 14:05
Is a corrupt little thing. My investments in aim amount to here and agq( which I'm out of once the test results are released this week) I dumped my brd shares with a profit, although I do think that's another Sar for me. Mtr, ukog and pvr have all been sold off now for a small loss or gain. The guff you can read on those boards, for me this is a sound board which presents facts to help your research. I may go back to brd with an intent to hold long only.
Today's speech/presentation I feel is going to be great, we may well have produced a best in class molecule here with a higher chance of it gaining royalties. Let's hope so.

Love peace and harmony.
Hondadave
Posts: 3,843
Off Topic
Opinion:No Opinion
Price:0.85
sp
Today 14:00
Not exactly going potty is it?
Oops, back on the naughty step for me.
potnak
Posts: 700
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.85
RE: Obelix
Today 13:50
Been watching Val for a while now. Pleased I was still wary of them or I'd be looking at a loss too.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.